Two-time cancer survivor and Patient Power host, Andrew Schorr, speaks candidly with Dr. Philip Thompson, CLL specialist at MD Anderson Cancer Center. Together, they explore MRD (minimal residual disease) negativity and how this status impacts long-term disease results. Dr. Thompson discusses consolidation strategies that may positively impact 11q and 17p deletion patients as researchers seek answers for a cure.
What Does It Mean to Achieve MRD-Negat... - CLL America Support
What Does It Mean to Achieve MRD-Negative Status?
Written by
mcints
To view profiles and participate in discussions please or .
1 Reply
•
Nice perspective on this measure of treatment efficacy.
Not what you're looking for?
You may also like...
Choice of doctors
Ok so I've got a real dilemma. I'm on W&W. I have two top CLL specialists in two sister hospitals....
Anxiety
Not feeling very confident with the Dr that I have been referred to. Problem is where I live it is...
I’m unclear what to think of my diagnosis
I’m new here and not clear about the diagnosis given on my Flow Cytometry, which classified me with...
Good News from the Doctor Venetoclax is working!
I started my Venetoclax journey September 7th. A few bumps on the way up from 20mgs. to 400 mgs....
Low Platelets
I just got back from my visit to MD Anderson and had a platelet count of 89. My last readings from...
CLL diagnosis and diet